United States v. Langley., No. 20-50119 (9th Cir. 2021)

Annotate this Case
Justia Opinion Summary

In 2017, Langley pleaded guilty to possession of child pornography and was sentenced to time served and 10 years of supervised release. As required by 18 U.S.C. 3583(d), the conditions of Langley’s supervised release included that he “not commit [a] federal, state or local crime,” “not illegally possess a controlled substance,” and “refrain from any unlawful use of a controlled substance.” In 2017, Langley unsuccessfully sought amendment of the conditions of supervised release to permit him to use medical marijuana as allowed by California state law, to alleviate pain stemming from the amputation of his lower leg. Langley renewed the motion in 2020. Langley, who submitted a physician's opinion that marijuana was the best medical solution for his pain issues, argued that he has a fundamental Due Process Clause right to use medical marijuana.

The Ninth Circuit affirmed the denial of Langley’s renewed motion. The court held that it is bound by precedent that rejected the identical substantive due process claim. Even if state laws decriminalizing marijuana could constitute additional evidence under the test for determining whether a right is protected by the Due Process Clause, the court concluded that it is bound by its 2007 decision until it is overturned by a higher authority.

Court Description: Criminal. The panel affirmed the district court’s denial of Richard Langley’s renewed motion to amend the conditions of his supervised release to permit him to use medical marijuana as allowed by California state law. Langley, who submitted a report from a physician opining that marijuana was the best medical solution for his pain issues, argued that he has a fundamental constitutional right under the Fourteenth Amendment’s Due Process Clause to use medical marijuana. The panel held that it is bound by Raich v. Gonzales, 500 F.3d 8850 (9th Cir. 2007), which rejected the identical substantive due process claim. Langley argued that the panel is no longer bound by Raich’s conclusion in light of the increasing number of states that no longer criminalize the use of medical marijuana for medical purposes. The panel wrote that even if state laws decriminalizing marijuana could constitute additional evidence under the test applied in Raich for determining whether a right is protected by the Due Process Clause, the panel is bound by the holding in Raich until such time as it is overturned by a higher authority. UNITED STATES V. LANGLEY 3

Download PDF
FOR PUBLICATION UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT UNITED STATES OF AMERICA, Plaintiff-Appellee, No. 20-50119 D.C. Nos. 3:16-cr-00393-MMA-1 3:16-cr-00393-MMA v. RICHARD LANGLEY, AKA Richard M Langley, Defendant-Appellant. OPINION Appeal from the United States District Court for the Southern District of California Michael M. Anello, District Judge, Presiding Submitted August 30, 2021* Pasadena, California Filed November 16, 2021 Before: Sandra S. Ikuta, Mark J. Bennett, and Ryan D. Nelson, Circuit Judges. Per Curiam Opinion * The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). 2 UNITED STATES V. LANGLEY SUMMARY** Criminal The panel affirmed the district court’s denial of Richard Langley’s renewed motion to amend the conditions of his supervised release to permit him to use medical marijuana as allowed by California state law. Langley, who submitted a report from a physician opining that marijuana was the best medical solution for his pain issues, argued that he has a fundamental constitutional right under the Fourteenth Amendment’s Due Process Clause to use medical marijuana. The panel held that it is bound by Raich v. Gonzales, 500 F.3d 8850 (9th Cir. 2007), which rejected the identical substantive due process claim. Langley argued that the panel is no longer bound by Raich’s conclusion in light of the increasing number of states that no longer criminalize the use of medical marijuana for medical purposes. The panel wrote that even if state laws decriminalizing marijuana could constitute additional evidence under the test applied in Raich for determining whether a right is protected by the Due Process Clause, the panel is bound by the holding in Raich until such time as it is overturned by a higher authority. ** This summary constitutes no part of the opinion of the court. It has been prepared by court staff for the convenience of the reader. UNITED STATES V. LANGLEY 3 COUNSEL Doug Keller, The Law Office of Doug Keller, San Diego, California, for Defendant-Appellant. Zachary J. Howe, Assistant United States Attorney; Daniel E. Zipp, Assistant United States Attorney, Chief, Appellate Section, Criminal Division; Robert S. Brewer, Jr., United States Attorney; United States Attorney; United States Attorney’s Office, San Diego, California; for PlaintiffAppellee. OPINION PER CURIAM: This appeal asks us to revisit our prior decision that “federal law does not recognize a fundamental right to use medical marijuana,” Raich v. Gonzales, 500 F.3d 850, 866 (9th Cir. 2007), in light of the increasing number of states that no longer criminalize the use of marijuana for medical purposes. Because we are bound by our prior precedential opinions until they are overruled by a higher authority, Miller v. Gammie, 335 F.3d 889, 900 (9th Cir. 2003) (en banc), we decline to do so. I In 2017, Richard Langley pleaded guilty to possession of child pornography in violation of 18 U.S.C. § 2252(a)(4)(B). The district court sentenced Langley to time served (56 days) and a ten-year term of supervised release. As required by statute, 18 U.S.C. § 3583(d), the conditions of Langley’s 4 UNITED STATES V. LANGLEY supervised release included that he “not commit [a] federal, state or local crime,” “not illegally possess a controlled substance,” and “refrain from any unlawful use of a controlled substance.” In 2017, Langley moved the district court to amend the conditions of supervised release to permit him to use medical marijuana as allowed by California state law. See Cal. Health & Safety Code § 11362.5. According to Langley, marijuana helps him alleviate pain stemming from a motorcycle accident that resulted in the amputation of his right leg below the knee. The district court denied the motion. Langley renewed the motion in 2020. This time he supported his motion with a report from a physician opining that marijuana was the best medical solution for Langley’s pain issues. The district court again denied the motion, holding that because possession of marijuana is a violation of federal law, and Langley had no constitutional right to use medical marijuana, the court lacked authority to modify the “statutorily required condition that [Langley] not ‘commit another Federal, State, or local crime during the term of supervision.’” Langley timely appealed. We have jurisdiction under 28 U.S.C. § 1291. We review the conditions of supervised release imposed by a district court for an abuse of discretion, see United States v. Bee, 162 F.3d 1232, 1234 (9th Cir. 1998), and “review de novo whether a supervised release condition violates the Constitution.” United States v. Ochoa, 932 F.3d 866, 868–69 (9th Cir. 2019) (citation omitted). UNITED STATES V. LANGLEY 5 II Unless Langley has a constitutional right to use medical marijuana, the district court did not err in denying Langley’s motion to amend his conditions of supervised release. If a court places a defendant on a term of supervised release, it is required by statute to “order, as an explicit condition of supervised release, that the defendant not commit another Federal, State, or local crime during the term of supervision,” “that the defendant not unlawfully possess a controlled substance,” and that “the defendant refrain from any unlawful use of a controlled substance.” 18 U.S.C. § 3583(d). Under the federal Controlled Substances Act (CSA), marijuana is an enumerated controlled substance. See 21 U.S.C. § 812(b)–(c) (“Marihuana” listed on Schedule I of controlled substances). Therefore, the applicable federal statutes precluded the court from granting Langley’s motion. See 18 U.S.C. § 3583(d), 21 U.S.C. § 812(b)–(c). Accordingly, we turn to Langley’s argument that the district court erred in denying his motion because he has a fundamental constitutional right under the Fourteenth Amendment’s Due Process Clause to use medical marijuana under these circumstances. Langley defines the purported substantive right at issue as “the right to make a life-shaping decision on a physician’s advice to use medical marijuana to preserve bodily integrity, avoid intolerable pain, and preserve life, when all other prescribed medications and remedies have failed.” In Raich, we rejected the claim that this purported right, which was defined using identical language, is a fundamental right. See 500 F.3d at 866. In Raich, a plaintiff sought to enjoin the enforcement of the CSA to prevent her from using 6 UNITED STATES V. LANGLEY marijuana to treat her inoperable, life-threatening brain tumor. Id. at 855–57. The plaintiff argued, among other things, that she had a substantive due process right to use medical marijuana in that context. Raich rejected her argument. Applying the two-part test set out in Washington v. Glucksberg, 521 U.S. 702, 719–20 (1997), for determining whether a right is protected by the Due Process Clause, Raich first defined the asserted fundamental right at issue as the “right to make a life-shaping decision on a physician’s advice to use medical marijuana to preserve bodily integrity, avoid intolerable pain, and preserve life, when all other prescribed medications and remedies have failed.” 500 F.3d at 864. Raich then determined that this right is not, objectively, “deeply rooted in this Nation’s history and tradition,” and “implicit in the concept of ordered liberty,” such that “neither liberty nor justice would exist if [it] were sacrificed,” id. (quoting Glucksberg, 521 U.S. at 720–21). Therefore, Raich held that “federal law does not recognize a fundamental right to use medical marijuana prescribed by a licensed physician to alleviate excruciating pain and human suffering.” Id. at 866. Raich is controlling here. The substantive due process right claimed by Langley is identical to the right claimed by the plaintiffs in Raich, and Langley does not argue otherwise. Therefore we are bound by Raich’s conclusion that medical marijuana use is not “deeply rooted in this Nation’s history and tradition” or “implicit in the concept of ordered liberty,” 500 F.3d at 864, and so federal law does not recognize a substantive due process right to use medical marijuana, even where doing so provides important medical benefits. UNITED STATES V. LANGLEY 7 Langley argues that we are no longer bound by Raich’s conclusion. He points out that Raich acknowledged that widespread legal recognition of a practice can sometimes provide additional evidence that a right is fundamental, id. at 865–66 (discussing Lawrence v. Texas, 439 U.S. 558, 571–72 (2003)), and that 36 states and the District of Columbia no longer criminalize the use of marijuana for medical purposes. But this argument misunderstands our rule that “a published decision of this court constitutes binding authority which must be followed unless and until overruled by a body competent to do so,” Gonzalez v. Arizona, 677 F.3d 383, 389 n.4 (9th Cir. 2012) (cleaned up), aff’d sub nom. Arizona v. Inter Tribal Council of Arizona, Inc., 570 U.S. 1 (2013). Raich’s conclusion that medical marijuana use is not “deeply rooted in this Nation’s history and tradition” or “implicit in the concept of ordered liberty,” 500 F.3d at 864, is binding on us until it is overturned by a higher authority. Even if state laws decriminalizing marijuana use could constitute additional evidence under the Glucksberg test, we are bound by our holding in Raich until such time as a higher authority determines that there is a fundamental right to medical marijuana use that we are “blind to” today, id. at 866. See Wilson v. Lynch, 835 F.3d 1083, 1098 n.9 (9th Cir. 2016) (holding that a substantive due process claim based on a fundamental right to use medical marijuana is “foreclosed by our decision in Raich”). AFFIRMED.
Primary Holding

Ninth Circuit affirms the denial of a motion to amend the conditions of supervised release to allow the defendant to use medical marijuana, rejecting a due process argument.


Disclaimer: Justia Annotations is a forum for attorneys to summarize, comment on, and analyze case law published on our site. Justia makes no guarantees or warranties that the annotations are accurate or reflect the current state of law, and no annotation is intended to be, nor should it be construed as, legal advice. Contacting Justia or any attorney through this site, via web form, email, or otherwise, does not create an attorney-client relationship.

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.